Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology (NASDAQ:ALGN) hosted its 2025 Global Faculty Meeting, bringing together over 100 Invisalign® and iTero™-trained doctor educators for comprehensive education workshops. The event, themed "Innovate. Collaborate. Educate.," focused on Align's latest innovations, clinical evidence, and best practices for treating patients of all ages.
Key highlights include the launch of a new clinical evidence webpage featuring 800+ peer-reviewed publications, expansion of the Align Global Gallery™ to over 1,500 case studies, and the continuation of the research awards program, which has provided $4 million in grants since 2010. The meeting featured presentations on patient demand, practice growth, clinical insights, and case discussions, reinforcing Align's commitment to advancing digital orthodontics and dentistry.
Align Technology (Nasdaq: ALGN) has filed a complaint with the U.S. International Trade Commission (ITC) against Angelalign Technology for alleged patent infringement related to clear aligner products. The company is seeking both an exclusion order to prevent importation of infringing products and a cease-and-desist order to stop sales of existing products in the U.S. market.
This legal action follows previous patent infringement litigation filed in August across multiple jurisdictions including the U.S. District Court, China Intermediate People's Court, and European Unified Patent Court. The complaint alleges that Angelalign's products unauthorized incorporate Align's patented technologies.
Align Technology (NASDAQ:ALGN) hosted its 2025 Invisalign® GP Summit, bringing together over 700 doctors and practice team members for a three-day educational event. The summit showcased the latest innovations in digital orthodontics, including the Invisalign® System, iTero™ scanners, and the Align™ Digital Platform.
The event featured an Innovation Hub demonstrating new technologies like the iTero Lumina™ intraoral scanner, Invisalign® Smile Video, and Align™ X-ray Insights. Align also launched the Women's Smile Collective initiative to support women in dentistry and celebrated the milestone of 20 million Invisalign® smiles transformed.
Align Technology (NASDAQ: ALGN), a leading medical device company specializing in clear aligners and digital dentistry solutions, has announced its participation in three upcoming financial conferences in September 2025.
The company's executives, including EVP Global Finance and CFO John Morici and VP Finance Shirley Stacy, will present at the 2025 Wells Fargo Healthcare Conference (Sept 3), Morgan Stanley 23rd Annual Global Healthcare Conference (Sept 9), and Baird Global Healthcare Conference (Sept 10). All presentations will be accessible via webcast through Align's Investor Relations website.
The company has treated over 20.8 million patients with its Invisalign System and serves more than 286,400 doctor customers globally.Align Technology (NASDAQ:ALGN) has initiated patent infringement lawsuits against Angelalign Technology (6699.HK) in the United States, Europe, and China. The litigation targets alleged infringement of Align's patents covering multilayer aligner materials, treatment planning, and advanced aligner features.
Align emphasizes its significant R&D investment of over $300 million annually and approximately $2 billion since 2001. The company maintains extensive global operations, including clinical treatment planning centers across multiple countries and manufacturing facilities in Mexico, Poland, and China, supporting over 20 million Invisalign® patients treated worldwide.
Align Technology (NASDAQ: ALGN) has announced plans to repurchase $200 million of its common stock through open market transactions under its $1.0 billion stock repurchase program approved in April 2025.
The buyback will be executed through a Rule 10b5-1 trading plan and is expected to be completed by January 2026, funded with cash on hand. As of June 30, 2025, Align had approximately 72.5 million shares outstanding and $901.2 million in cash and cash equivalents.
The company's management emphasizes this decision reflects confidence in their long-term strategy and market opportunity, while maintaining focus on strategic execution and disciplined investments despite macroeconomic uncertainties.
Align Technology (Nasdaq: ALGN) announced that President and CEO Joe Hogan has personally purchased approximately $1 million of Align's common stock. This purchase adds to his previous investments, totaling approximately $8 million in stock purchases since his last sale in 2021.
Hogan emphasized his confidence in Align's long-term value and commitment to increasing shareholder value through strategic investments in growth and next-generation technologies. Despite acknowledging ongoing macroeconomic uncertainties, the company maintains its focus on transforming treatment through its Invisalign® System, iTero™ scanners, and exocad™ software, serving over 286,400 doctor customers and targeting a 600 million consumer market opportunity worldwide.
Align Technology (NASDAQ:ALGN) reported mixed Q2 2025 financial results with total revenues of $1,012.4 million, up 3.4% sequentially but down 1.6% year-over-year. Clear Aligner revenues were $804.6 million, declining 3.3% year-over-year, while Imaging Systems revenues grew 5.6% to $207.8 million.
The company reported Q2 GAAP operating income of $163.0 million with a 16.1% margin, and non-GAAP operating margin of 21.3%. GAAP diluted EPS was $1.72, with non-GAAP EPS at $2.49.
Align announced a restructuring plan including workforce reductions and manufacturing optimization, expecting $150-170 million in one-time charges in H2 2025. The company aims to achieve GAAP operating margins of 13-14% and non-GAAP margins above 22.5% in FY 2025.
Align Technology (NASDAQ:ALGN) has announced the commercial launch of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in Malaysia. This breakthrough technology is designed to treat Class II skeletal malocclusion in growing patients aged 10-16 while simultaneously straightening their teeth.
The new system represents a significant advancement in treating Class II malocclusions, which affect 30-45% of cases globally. The technology features integrated solid occlusal blocks with laser welding for improved durability and engagement, enabling earlier mandibular advancement in cases with deep bite. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.
The product is currently available in select APAC markets with further expansion planned for 2025.Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign Palatal Expander System in Malaysia, following its notification as a Class B medical device by the Malaysia Medical Device Authority. This innovative system, Align's first direct 3D printed orthodontic appliance, offers a metal-free alternative to traditional palatal expanders for skeletal and dental expansion.
The system consists of customized removable devices created using AI-driven orthodontic software and iTero intraoral digital scans. When combined with Invisalign First aligners, it provides a comprehensive early intervention treatment solution for growing patients. The technology is particularly significant for Phase 1 treatment, which represents 20% of orthodontic case starts annually and targets patients aged 6-10 years.
The expansion is now available across multiple Asia Pacific markets, including Australia, New Zealand, Hong Kong, Singapore, Vietnam, Japan, Thailand, India, and Malaysia.